1-EBIO Enhances Function of Mutant CFTR in Cystic Fibrosis Patients
Author Information
Author(s): Eva K. Roth, Stephanie Hirtz, Julia Duerr, Daniel Wenning, Irmgard Eichler, Hans H. Seydewitz, Margarida D. Amaral, Marcus A. Mall
Primary Institution: University of Heidelberg, Heidelberg, Germany
Hypothesis
Can the K+ channel opener 1-EBIO improve CFTR function in rectal biopsies from cystic fibrosis patients?
Conclusion
1-EBIO significantly enhances Cl− secretion in rectal tissues from cystic fibrosis patients with residual CFTR function.
Supporting Evidence
- 1-EBIO activated CFTR-mediated Cl− secretion in control tissues.
- 1-EBIO potentiated cAMP-induced Cl− secretion by 39.2±6.7% in control tissues.
- 1-EBIO increased cAMP-induced Cl− secretion by 44.4±11.5% in CF tissues with residual CFTR function.
Takeaway
This study shows that a drug called 1-EBIO can help improve the function of a protein that doesn't work well in some cystic fibrosis patients, helping them secrete important salts.
Methodology
The study involved rectal biopsies from 47 cystic fibrosis patients and 57 age-matched controls, measuring CFTR-mediated Cl− secretion using micro-Ussing chambers.
Limitations
The study only included rectal biopsies and may not fully represent CFTR function in other tissues.
Participant Demographics
47 cystic fibrosis patients (mean age 10.4 years) and 57 age-matched non-CF controls (mean age 11.4 years).
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website